We recently published an article titled These 10 Firms Led This Week’s Rally. In this article, we are going to take a look at where Royalty Pharma plc (NASDAQ:RPRX) stands against the other stocks.

Blood Disorder Therapy: Australian drugmaker CSL Ltd acquired exclusive global rights to Hemgenix in June 2020 from uniQure, which would retain the rights to future milestones totaling up to $1.5 ...